EUR 1.76
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 37.23 Million EUR | -15.13% |
2022 | 43.87 Million EUR | 2.1% |
2021 | 42.97 Million EUR | 116.24% |
2020 | 19.87 Million EUR | 21.89% |
2019 | 16.3 Million EUR | -13.7% |
2018 | 18.89 Million EUR | 2.22% |
2017 | 18.48 Million EUR | 22.96% |
2016 | 15.03 Million EUR | -8.84% |
2015 | 16.48 Million EUR | -18.32% |
2014 | 20.18 Million EUR | 26.15% |
2013 | 16 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 34.45 Million EUR | -7.47% |
2024 Q2 | 34.45 Million EUR | 0.0% |
2023 FY | 34.76 Million EUR | -20.78% |
2023 Q4 | 37.23 Million EUR | 0.0% |
2023 Q2 | 33.61 Million EUR | -6.45% |
2023 Q3 | 37.23 Million EUR | 10.79% |
2023 Q1 | 35.93 Million EUR | -18.11% |
2022 Q2 | 45.63 Million EUR | -2.48% |
2022 Q4 | 43.87 Million EUR | -2.6% |
2022 FY | 43.87 Million EUR | 2.1% |
2022 Q1 | 46.79 Million EUR | 8.88% |
2022 Q3 | 45.04 Million EUR | -1.27% |
2021 Q1 | 25.61 Million EUR | 28.01% |
2021 FY | 42.97 Million EUR | 116.24% |
2021 Q4 | 42.97 Million EUR | -2.74% |
2021 Q3 | 44.18 Million EUR | 85.87% |
2021 Q2 | 23.77 Million EUR | -7.18% |
2020 Q2 | 17.73 Million EUR | -9.7% |
2020 Q1 | 19.64 Million EUR | 20.48% |
2020 FY | 19.87 Million EUR | 21.89% |
2020 Q3 | 21.08 Million EUR | 18.87% |
2020 Q4 | 20 Million EUR | -5.11% |
2019 Q1 | 22.12 Million EUR | 5.87% |
2019 Q2 | 20.15 Million EUR | -8.92% |
2019 Q3 | 18.22 Million EUR | -9.56% |
2019 FY | 16.3 Million EUR | -13.7% |
2019 Q4 | 16.3 Million EUR | -10.54% |
2018 Q4 | 20.89 Million EUR | 0.0% |
2018 Q1 | 21.34 Million EUR | 3.85% |
2018 Q3 | 20.89 Million EUR | -2.1% |
2018 FY | 18.89 Million EUR | 2.22% |
2018 Q2 | 21.34 Million EUR | 0.0% |
2017 Q1 | 18.52 Million EUR | 7.88% |
2017 Q3 | 20.55 Million EUR | 10.94% |
2017 Q4 | 20.55 Million EUR | 0.0% |
2017 FY | 18.48 Million EUR | 22.96% |
2017 Q2 | 18.52 Million EUR | 0.0% |
2016 Q1 | 17.29 Million EUR | -7.57% |
2016 FY | 15.03 Million EUR | -8.84% |
2016 Q2 | 17.29 Million EUR | 0.0% |
2016 Q4 | 17.17 Million EUR | 0.0% |
2016 Q3 | 17.17 Million EUR | -0.68% |
2015 FY | 16.48 Million EUR | -18.32% |
2015 Q4 | 18.7 Million EUR | -6.01% |
2015 Q1 | 20.2 Million EUR | 0.09% |
2015 Q3 | 19.9 Million EUR | -3.16% |
2015 Q2 | 20.55 Million EUR | 1.73% |
2014 Q4 | 20.18 Million EUR | 8.98% |
2014 Q2 | 15.96 Million EUR | 11.31% |
2014 Q1 | 14.34 Million EUR | -10.39% |
2014 FY | 20.18 Million EUR | 26.15% |
2014 Q3 | 18.52 Million EUR | 16.04% |
2013 Q2 | 16.56 Million EUR | -3.28% |
2013 FY | 16 Million EUR | 0.0% |
2013 Q3 | 17.1 Million EUR | 3.26% |
2013 Q4 | 16 Million EUR | -6.45% |
2013 Q1 | 17.12 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Evrofarma SA | 31.13 Million EUR | -19.618% |
Kri-Kri Milk Industry S.A. | 50.89 Million EUR | 26.835% |
Loulis Food Ingredients S.A. | 98.69 Million EUR | 62.27% |